Status of Sentinel Lymph Node Biopsy in Vulvar and Cervical Cancer.
cervical cancer
micrometastases
sentinel lymph node
ultrastaging
vulvar cancer
Journal
Geburtshilfe und Frauenheilkunde
ISSN: 0016-5751
Titre abrégé: Geburtshilfe Frauenheilkd
Pays: Germany
ID NLM: 0370732
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
27
07
2020
accepted:
26
10
2020
entrez:
9
12
2020
pubmed:
10
12
2020
medline:
10
12
2020
Statut:
ppublish
Résumé
Assessment of lymphatic metastasis is an essential component of solid tumour staging. Sentinel lymph node (SLN) biopsy is a minimally invasive procedure that allows regional lymph node involvement by tumour to be estimated by selectively examining the sentinel lymph node while minimising the morbidity of systematic lymph node dissection. Within the group of genital cancers, the diagnostic value of SLN biopsy is rated differently. For selected patients with early-stage vulvar cancer (unifocal primary tumour < 4 cm, clinically negative inguinal lymph nodes) the SLN technique is already an established procedure in the guidelines of the German Society for Gynaecology and Obstetrics (DGGG)/German Cancer Society (DKG) and the recommendations of the European Society of Gynaecological Oncology (ESGO). For cervical cancer, SLN biopsy has not yet been sufficiently standardised but can be considered for patients without risk factors with a primary tumour size < 2 cm. The SLN is identified by combined use of radioactive
Identifiants
pubmed: 33293729
doi: 10.1055/a-1128-0168
pii: 11280168
pmc: PMC7714557
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1212-1220Informations de copyright
The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Déclaration de conflit d'intérêts
Conflict of Interest/Interessenkonflikt The authors declare that they have no conflict of interest./Die Autorinnen/Autoren geben an, dass kein Interessenkonflikt besteht.
Références
Ann Oncol. 2004 Jun;15(6):870-4
pubmed: 15151942
CMAJ. 2008 Mar 25;178(7):855-62
pubmed: 18362381
Gynecol Oncol. 2011 Nov;123(2):230-5
pubmed: 21893335
Int J Gynecol Cancer. 2019 Mar;29(3):447-452
pubmed: 30833435
Arch Surg. 1992 Apr;127(4):392-9
pubmed: 1558490
J Obstet Gynaecol Can. 2012 Nov;34(11):1053-1065
pubmed: 23231843
Int J Gynecol Cancer. 2017 May;27(4):805-812
pubmed: 28399034
Int J Gynecol Cancer. 2007 Jan-Feb;17(1):154-8
pubmed: 17291247
Am J Surg Pathol. 2008 Sep;32(9):1336-43
pubmed: 18670356
J Clin Oncol. 2011 May 1;29(13):1686-91
pubmed: 21444878
Br J Cancer. 2014 Jun 10;110(12):2837-46
pubmed: 24867697
Gynecol Oncol. 2008 Nov;111(2):282-8
pubmed: 18804850
Eur J Nucl Med Mol Imaging. 2007 Mar;34(3):384-91
pubmed: 17006693
Front Surg. 2020 Jun 12;7:31
pubmed: 32596252
Gynecol Oncol. 2015 May;137(2):264-9
pubmed: 25727652
Ann Surg Oncol. 2016 Sep;23(9):2959-65
pubmed: 27126631
Int J Gynecol Cancer. 2011 Apr;21(3):559-64
pubmed: 21430459
Hell J Nucl Med. 2014 Sep-Dec;17(3):184-9
pubmed: 25397623
Anticancer Res. 2008 Jan-Feb;28(1B):515-7
pubmed: 18383894
Gynecol Oncol. 2020 Jan;156(1):93-99
pubmed: 31839343
Lancet Oncol. 2010 Jul;11(7):646-52
pubmed: 20537946
Gynecol Oncol. 2013 Jul;130(1):237-45
pubmed: 23612317
J Clin Oncol. 2008 Jun 20;26(18):2943-51
pubmed: 18565880
J Minim Invasive Gynecol. 2016 Feb 1;23(2):186-93
pubmed: 26518716
Gynecol Oncol. 2009 Jun;113(3):301-5
pubmed: 19297013
Gynecol Oncol. 2011 Aug;122(2):269-74
pubmed: 21529908
Gynecol Oncol. 2013 Feb;128(2):155-9
pubmed: 23201592
J Natl Cancer Inst. 2015 Jan 24;107(3):
pubmed: 25618900
Int J Gynaecol Obstet. 2016 Apr;133(1):69-75
pubmed: 26868069
Ann Surg Oncol. 2016 Aug;23(8):2508-14
pubmed: 26856721
Gynecol Oncol. 2020 Sep;158(3):576-583
pubmed: 32595022
Gynecol Oncol. 2012 Dec;127(3):462-6
pubmed: 22943880
Gynecol Oncol. 2016 Jan;140(1):8-14
pubmed: 26428940
Gynecol Oncol. 2015 May;137(2):351-61
pubmed: 25703673
J Natl Compr Canc Netw. 2019 Jan;17(1):64-84
pubmed: 30659131
Histopathology. 2020 Jan;76(1):139-150
pubmed: 31846525
Gynecol Oncol. 2005 Apr;97(1):151-4
pubmed: 15790451
Obstet Gynecol. 1994 Aug;84(2):163-7
pubmed: 8041523
J Clin Oncol. 2012 Nov 1;30(31):3786-91
pubmed: 22753905
Geburtshilfe Frauenheilkd. 2018 Jan;78(1):54-62
pubmed: 29375146
Gynecol Oncol. 2006 Nov;103(2):649-53
pubmed: 16780935
J Clin Oncol. 2007 Apr 20;25(12):1588-95
pubmed: 17443001
Gynecol Oncol. 2012 Mar;124(3):496-501
pubmed: 22120175
J Clin Oncol. 2008 Feb 20;26(6):884-9
pubmed: 18281661
Ann Surg Oncol. 2013 Feb;20(2):413-22
pubmed: 22911367
Gynecol Oncol. 2016 Oct;143(1):83-86
pubmed: 27421753
Gynecol Oncol. 2017 Apr;145(1):96-101
pubmed: 28188015
Cancers (Basel). 2020 Apr 25;12(5):
pubmed: 32344814
Gynecol Oncol. 2006 Oct;103(1):35-44
pubmed: 16600355
Int J Gynecol Cancer. 2009 May;19(4):708-11
pubmed: 19509576
Jpn J Clin Oncol. 2019 Jun 1;49(6):495-500
pubmed: 31070770
Acta Obstet Gynecol Scand. 2009;88(11):1209-14
pubmed: 19824870
CA Cancer J Clin. 2017 Jan;67(1):7-30
pubmed: 28055103
Ann Surg Oncol. 2016 Jul;23(7):2183-91
pubmed: 26714944
Gynecol Oncol. 2019 Jan;152(1):202-207
pubmed: 30318103
Eur J Obstet Gynecol Reprod Biol. 2010 Sep;152(1):91-5
pubmed: 20579801
Breast Cancer. 1999;6(1):13-22
pubmed: 18841504
J Cancer Res Clin Oncol. 2017 Oct;143(10):2039-2048
pubmed: 28828528
Gynecol Oncol. 2003 Nov;91(2):378-82
pubmed: 14599869